Robert McGregor

Robert McGregor is a Project Leader at The Boston Consulting Group's Zurich office. He has a PhD in medical imaging from the ETH and is a core member of BCG's Health Care practice, leading client teams on strategic and commercial topics in medtech and pharma.

Editors’ Note: This blog is part 1 of a series on the MEAT value-based procurement project, an initiative that advocates towards a shift from price-based procurement of medical technology towards value-based procurement. It does so by defining a Most Economically Advantageous Tendering (MEAT) framework that includes the value of medical technologies, services and solutions in procurement processes across Europe. Read part 2 and part 3 . If you would like to contribute please contact the MedTech Views editorial team at info@medtechviews.eu . MedTech Europe has partnered with The Boston Consulting Group to define a new framework for most economically advantageous tendering in medtech. One of the major challenges we face as a society is growth in the demand for, and cost of, health care services; growth which continues despite myriad efforts by governments, health systems, and payers to contain it. At the same time, quality of care is highly variable. For example, if you were to undergo a radical prostatectomy even in the Netherlands, you would want to choose your hospital carefully. The worst performing hospitals there have nine times higher complication rates post-surgery than the best performing hospitals. This variation in outcomes is by no means an exception, and it highlights the lack of focus and lack of data on what patients care about most – outcomes. In their book "Redefining Health Care," Michael Porter and Elizabeth Teisberg define value in health care as "the health outcomes achieved per dollar spent", a definition that lays the foundation for value-based health care. This concept is increasingly being applied as the key paradigm by which to measure health delivery. It has the potential to align all stakeholders: patients, clinicians, policymakers, payers and industry around a common viewpoint, and is an especially attractive way to shift the thinking from considering cost and...